Home > News > Nanogen Shares Nosedive as Q2 Loss Nearly Doubles
August 4th, 2004
Nanogen Shares Nosedive as Q2 Loss Nearly Doubles
Nanogen Inc., maker of the NanoChip molecular diagnostics system for biologic research, saw its stock drop nearly 21 percent today after posting a second-quarter loss that almost doubled its loss of a year ago. Nanogen shares (Nasdaq: NGEN) fell 99 cents, or 20.6 percent, to close at $3.81 today. The firm has a market cap of $97.65 million.
Graphenea sales more than double in 2014 January 29th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014
Harris & Harris Group to Host Conference Call on Third Quarter 2014 Financial Results on November 12, 2014 November 3rd, 2014